India · Delayed Price · Currency is INR Verve Therapeutics Statistics
Total Valuation
NSE:THELEELA has a market cap or net worth of INR 138.07 billion. The enterprise value is 176.90 billion.
| Market Cap | 138.07B |
| Enterprise Value | 176.90B |
Important Dates
The last earnings date was Tuesday, July 22, 2025.
| Earnings Date | Jul 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:THELEELA has 333.96 million shares outstanding. The number of shares has increased by 54.10% in one year.
| Current Share Class | 333.96M |
| Shares Outstanding | 333.96M |
| Shares Change (YoY) | +54.10% |
| Shares Change (QoQ) | +65.99% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 6.09% |
| Float | 80.46M |
Valuation Ratios
The trailing PE ratio is 85.29 and the forward PE ratio is 44.82. NSE:THELEELA's PEG ratio is 0.48.
| PE Ratio | 85.29 |
| Forward PE | 44.82 |
| PS Ratio | 10.08 |
| PB Ratio | 3.83 |
| P/TBV Ratio | 4.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.48 |
Enterprise Valuation
| EV / Earnings | 134.44 |
| EV / Sales | 12.91 |
| EV / EBITDA | 27.01 |
| EV / EBIT | 34.17 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.15 |
| Debt / EBITDA | 6.32 |
| Debt / FCF | n/a |
| Interest Coverage | 1.22 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 5.95M |
| Profits Per Employee | 571,363 |
| Employee Count | 2,303 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:THELEELA has paid 653.54 million in taxes.
| Income Tax | 653.54M |
| Effective Tax Rate | 33.22% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 41.28 |
| Average Volume (20 Days) | 60,363 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:THELEELA had revenue of INR 13.70 billion and earned 1.32 billion in profits. Earnings per share was 4.85.
| Revenue | 13.70B |
| Gross Profit | 9.51B |
| Operating Income | 5.18B |
| Pretax Income | 1.97B |
| Net Income | 1.32B |
| EBITDA | 6.43B |
| EBIT | 5.18B |
| Earnings Per Share (EPS) | 4.85 |
Balance Sheet
The company has 3.07 billion in cash and 41.42 billion in debt, giving a net cash position of -38.34 billion or -114.81 per share.
| Cash & Cash Equivalents | 3.07B |
| Total Debt | 41.42B |
| Net Cash | -38.34B |
| Net Cash Per Share | -114.81 |
| Equity (Book Value) | 36.05B |
| Book Value Per Share | 128.65 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 69.40%, with operating and profit margins of 37.80% and 9.61%.
| Gross Margin | 69.40% |
| Operating Margin | 37.80% |
| Pretax Margin | 14.36% |
| Profit Margin | 9.61% |
| EBITDA Margin | 46.91% |
| EBIT Margin | 37.80% |
| FCF Margin | n/a |
Dividends & Yields
NSE:THELEELA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -54.10% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.95% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |